It is a trading private limited company based in Hyderabad, Telangana, India, established in 2013.
2013 | Hyderabad, Telangana, India | ActiveErudite Pharma Private Limited, a active private limited company, was established on 02 May 2013 in Hyderabad, Telangana, India. Engaging in other wholesale within the trade sector, it holds CIN: U24232TG2013PTC087456. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a active non-compliant status. Its leadership includes Sindigerikaranam Srinivasarao (Additional Director), Raghavendra Rao Karanam (Additional Director), Yathirajam Raja Raghava Rao (Director). It holds ₹1.50 M open charges and no settled loans. Its latest AGM occurred on 30 September 2022, with the balance sheet filed on 31 March 2022. It is based at H. No. 2-6-561, Jayapuri Colony, Hyderabad, Telangana, 500068.
U24232TG2013PTC087456
087456
02 May 2013
₹0.10 M
₹0.10 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Erudite Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sindigerikaranam Srinivasarao | Additional Director | 14 Dec 2021 | Current |
| Raghavendra Rao Karanam | Additional Director | 14 Dec 2021 | Current |
| Yathirajam Raja Raghava Rao | Director | 02 May 2013 | Current |
| Sindigeri Karanam Yamini Parimala | Director | 02 May 2013 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Erudite Pharma Private Limited, for the financial year ended 2017, experienced significant growth in revenue, with a 15.07% increase. The company also saw a substantial improvement in profitability, with a 52.71% increase in profit. The company's net worth Soared by an impressive increase of 17.2%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2017, Erudite Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹1,500,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Aug 2018 | State Bank Of India | ₹1.50 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Erudite Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Erudite Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Erudite Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Erudite Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records. was documented.
Erudite Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Hyderabad. was recorded as a recent event.
Progress on Sindigerikaranam Srinivasarao was appointed as a Additional Director was appointed as a Additional Director on 14 Dec 2021 & has been associated with this company since 3 years 11 months . was documented.
The activity Raghavendra Rao Karanam was appointed as a Additional Director was appointed as a Additional Director on 14 Dec 2021 & has been associated with this company since 3 years 11 months . was completed.
The activity A charge with State Bank Of India amounted to Rs. 1.50 M with Charge ID 100218290 was registered on 30 Aug 2018. was completed.
The activity Yathirajam Raja Raghava Rao was appointed as a Director was appointed as a Director on 02 May 2013 & has been associated with this company since 12 years 6 months . was completed.
The CIN of Erudite Pharma Private Limited is U24232TG2013PTC087456.
Erudite Pharma Private Limited is headquartered at H. No. 2-6-561, Jayapuri Colony, Hyderabad, Telangana, 500068.
Erudite Pharma Private Limited was incorporated on 02 May 2013.
The current directors of Erudite Pharma Private Limited are
The primary industry of Erudite Pharma Private Limited is Trade.
Erudite Pharma Private Limited is unlisted.
The authorized capital of Erudite Pharma Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Erudite Pharma Private Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX